
ALZHEIMER’S DRUG DISCOVERY FOUNDATION’S DIAGNOSTICS ACCELERATOR (DXA) Invests $1.4M in ViewMind’s technology.
This investment highlights and supports the advancement of its brain health assessment platform, ViewMind Atlas™. NEW YORK CITY, NY, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- ViewMind Inc. has secured a strategic investment of $1.4M from the …